Psychiatric NP Scope of Practice for Depression in New York

If you’re a psychiatrist or PMHNP managing depression, you’ve probably wondered: Can I actually prescribe controlled substances via telehealth without seeing patients in person? The answer in 2026 is yes — with some important caveats. Let’s cut through the confusion and talk about what these rules mean for your practice.

The Bottom Line: What You Can Do Right Now (2026)

Here’s the deal: Through December 31, 2026, you can prescribe controlled substances via telehealth to new patients without an initial in-person visit, thanks to the DEA’s fourth temporary extension of COVID-era flexibilities. This means you can manage a patient with depression who also needs Adderall for ADHD, or someone with severe anxiety requiring benzodiazepines, entirely through video visits.

For most depression medications — SSRIs, SNRIs, bupropion, mirtazapine — there are no federal restrictions at all. These aren’t controlled substances, so the DEA’s telehealth rules don’t apply. You’re only bound by your state’s standard of care requirements and telehealth regulations.

But here’s what you need to watch: After December 31, 2026, the rules will likely change. The DEA is finalizing new regulations that will probably require providers to obtain a special telemedicine registration to continue prescribing certain controlled substances remotely. For psychiatrists, that registration should be straightforward — the proposed rules specifically name board-certified psychiatrists as eligible for ‘Advanced Telemedicine Prescribing’ of Schedule II medications. For PMHNPs, the picture is less clear; the current proposal doesn’t explicitly include you, which could mean additional hurdles down the road.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Understanding the Federal Landscape: DEA Rules and the Ryan Haight Act

Let’s back up. Before COVID, the Ryan Haight Online Pharmacy Consumer Protection Act required at least one in-person medical evaluation before prescribing any controlled substance via telemedicine. This law was designed to stop ‘pill mills’ operating through online questionnaires, and it made perfect sense for that purpose. But it also created a massive barrier for legitimate telepsychiatry.

When the pandemic hit, the DEA suspended that in-person requirement under public health emergency authority. That was supposed to be temporary. The emergency ended in May 2023, but the DEA — recognizing that millions of patients were now receiving quality mental health care via telehealth — has extended the flexibilities four times. The latest extension runs through the end of 2026.

What the New DEA Rules Will Likely Bring

On January 16, 2025, the DEA announced proposed rules to permanently address telehealth prescribing. Here’s what matters for depression providers:

Special Registration for Telemedicine: Providers who want to prescribe Schedule III-V controlled substances (like ketamine, testosterone, some sleep aids) via telehealth would apply for a basic telemedicine special registration. For Schedule II substances (stimulants like Adderall, Vyvanse, methylphenidate), the DEA proposes an ‘Advanced Telemedicine Prescribing’ registration available only to:

• Board-certified psychiatrists
• Hospice and palliative care physicians
• Nursing home/long-term care physicians
• Certain pediatric specialists

Notice who’s missing from that list? Psychiatric nurse practitioners. The current proposal doesn’t include PMHNPs in the Schedule II telemedicine category, though the DEA is soliciting comments on expanding it. If you’re a PMHNP who regularly prescribes stimulants for treatment-resistant depression or ADHD comorbidity, pay attention to the comment period and make your voice heard.

Platform Registration: Telehealth companies that facilitate controlled substance prescribing will need to register with the DEA. For individual providers, this mainly means the platform you work through (like Klarity Health) will need to meet federal standards — but that’s on the platform, not you.

What This Means for Depression Treatment: Most antidepressants aren’t controlled substances, so these rules won’t affect your bread-and-butter prescribing. But psychiatric care often requires flexibility — augmenting an SSRI with a stimulant for treatment-resistant depression, managing co-occurring ADHD, prescribing a short-term benzodiazepine for severe anxiety during antidepressant titration. Under the new rules, psychiatrists should be able to continue that full scope of care via telehealth. PMHNPs might face new limitations unless the final rules expand the eligible provider types.

State-by-State Reality: Where You Practice Matters

Federal DEA rules set the floor, but states can add their own requirements. Some states have embraced telehealth psychiatry with open arms; others remain cautious. Here’s what you need to know for the major markets:

California: NP Independence and Telehealth-Friendly Environment

California recently made a huge leap forward for PMHNPs. Assembly Bill 890 (2020) created a pathway for nurse practitioners to practice independently without physician supervision. As of January 2024, experienced PMHNPs can become ‘104 NPs’ with full independent practice authority after completing:

• 3 years (4,600 hours) of practice
• National certification in their specialty (psychiatric-mental health)
• Additional transition-to-practice requirements

This means if you’re a PMHNP in California with a few years of experience, you can run your own telepsychiatry practice, diagnose and treat depression, and prescribe medications — including controlled substances — without a supervising psychiatrist.

For telehealth prescribing, California has no state-level in-person exam requirement. You establish a valid patient relationship via a live video visit (audio-only is permitted for mental health services if it meets the standard of care). You can prescribe antidepressants, stimulants, benzodiazepines — whatever is clinically appropriate — as long as you follow standard documentation and safety protocols.

The catch: California isn’t part of the Interstate Medical Licensure Compact. If you’re licensed elsewhere and want to treat California patients, you’ll need a full California license. No shortcuts.

Texas: Collaboration Requirements and Chronic Pain Restrictions

Texas modernized its telehealth laws in 2017 (Senate Bill 1107), eliminating the old requirement for an in-person visit before any telemedicine encounter. Now, a psychiatrist can establish a valid patient relationship via live video and prescribe based on that encounter.

But Texas has two important limitations:

1. PMHNPs cannot practice independently. You must have a Prescriptive Authority Agreement with a Texas-licensed physician. This physician doesn’t need to be present during your telehealth visits, but you’re required to meet at least monthly to discuss cases, and they must be available for consultation. This is true whether you’re seeing patients in person or via telehealth.

2. Telehealth for chronic pain is heavily restricted. Texas explicitly prohibits treating chronic pain with controlled substances via telemedicine unless the patient has had an in-person visit within the last 90 days. This is aimed at pain management, not psychiatry — but it’s something to be aware of if you’re treating depression patients who also have chronic pain conditions.

For routine depression and anxiety management, these rules don’t create major barriers. A psychiatrist can prescribe SSRIs, SNRIs, even stimulants or benzodiazepines via video visits. PMHNPs just need to ensure they have that supervisory relationship documented.

Market context: Texas has 246 of its 254 counties designated as mental health shortage areas. Telepsychiatry is desperately needed. The state participates in the Interstate Medical Licensure Compact, so out-of-state psychiatrists can get licensed more easily if they qualify.

Florida: Psychiatric Exception for Schedule II Prescribing

Florida has one of the most interesting telehealth laws for psychiatry. The state allows out-of-state providers to register for a telehealth license without obtaining full Florida licensure (though you must renew it every two years and maintain malpractice coverage).

Here’s where it gets specific: Florida law prohibits prescribing Schedule II controlled substances via telehealth — except for four carved-out categories:

1. Treatment of psychiatric disorders
2. Inpatient hospital care
3. Hospice patients
4. Nursing home residents

That first exception is huge. It means you can prescribe Adderall, Ritalin, or other Schedule II stimulants via telehealth to a Florida patient with depression and ADHD, because that falls under ‘treatment of a psychiatric disorder.’ You can’t prescribe those same medications for weight loss or chronic fatigue via telehealth — but for mental health conditions, you’re covered.

For Schedule III-V controlled substances (benzodiazepines, sleep aids, etc.), there are no telehealth restrictions beyond federal law.

The NP catch in Florida: While some NPs gained independent practice authority in 2020, psychiatric nurse practitioners were explicitly excluded. PMHNPs in Florida still need a supervising physician and a written protocol on file. If you’re an out-of-state PMHNP wanting to treat Florida patients via telehealth, you’ll need both the telehealth registration and a Florida-licensed psychiatrist willing to supervise your practice.

New York: NP Independence After Experience Threshold

New York made PMHNPs’ lives easier in 2022 by making permanent a law allowing experienced nurse practitioners to practice without a collaborative agreement. Once you’ve completed 3,600 hours of practice, you can practice independently — no written physician agreement required, though you’re expected to maintain a ‘collaborative relationship’ for consultation.

For telehealth, New York has been progressive. The state allows video visits, and during COVID even permitted audio-only telehealth for mental health services (many of these flexibilities have been extended). There’s no state-level in-person exam requirement for prescribing.

The downside: Like California, New York isn’t in the Interstate Medical Licensure Compact. You need a full New York license to treat patients there, and getting one from out of state can be time-consuming.

Pennsylvania: Collaborative Agreements Still Required

Pennsylvania hasn’t passed full practice authority for nurse practitioners yet. PMHNPs need a collaborative agreement with a physician to practice and prescribe. The physician doesn’t have to co-sign every prescription, but the agreement must outline the scope of collaboration and be on file with the state Board of Nursing.

Pennsylvania doesn’t have a comprehensive telehealth statute (several bills have failed). However, the Department of State has made clear that licensed professionals can provide care via telemedicine as long as it meets the standard of care. There’s no requirement for an in-person visit before prescribing via telehealth.

Pennsylvania does mandate electronic prescribing for controlled substances (with limited exceptions), so make sure your telehealth platform supports EPCS.

The state joined the Interstate Medical Licensure Compact in 2021, which helps out-of-state psychiatrists get licensed. For PMHNPs, you’ll need that collaborative agreement even if you’re only seeing patients via telehealth.

Illinois: Full Practice Authority After 4,000 Hours

Illinois has been a leader in NP independence. PMHNPs can apply for Full Practice Authority after completing:

• 4,000 hours of collaborative practice
• 250 hours of continuing education in their specialty
• Additional pharmacology training (45 hours)

With FPA status, you can practice completely independently — diagnose depression, prescribe all medications including controlled substances, manage your own caseload. You’ll need your own Illinois controlled substance license and DEA registration.

Illinois passed a strong telehealth law in 2021 (Public Act 102-104) requiring insurance parity and prohibiting requirements for prior in-person visits. The state explicitly allows telehealth from any location and even permits audio-only visits for behavioral health when clinically appropriate.

One nuance: Illinois FPA-APRNs must have a consultation process with a physician if prescribing Schedule II opioids long-term. This doesn’t typically affect depression treatment (you’re not prescribing opioids for MDD), but it’s worth knowing.

Psychiatrist vs. PMHNP: Understanding Your Scope

Let’s be clear about the differences in scope of practice, because they affect how you can operate in telehealth:

Psychiatrists (MD/DO) have the broadest scope. You can:

• Diagnose and treat any mental health condition
• Prescribe any medication, including all schedules of controlled substances
• Practice independently in all 50 states (with appropriate licensure)
• Qualify for the DEA’s proposed ‘Advanced Telemedicine Prescribing’ registration for Schedule II substances

You don’t need supervision. You don’t need collaborative agreements. Your scope is limited only by your competence and state licensing laws.

PMHNPs are highly trained specialists in mental health, but your scope varies by state:

Full practice states (California after 3 years, New York after 3,600 hours, Illinois with FPA): You can diagnose and treat depression independently, prescribe all medications within your scope including controlled substances, and operate your own practice without physician oversight.

Restricted practice states (Texas, Florida, Pennsylvania): You must have a collaborative agreement or supervisory relationship with a physician. The physician doesn’t necessarily have to co-sign prescriptions or be present during visits, but the relationship must be documented and active. In some states, this affects your ability to prescribe certain controlled substances independently.

For depression specifically: Both psychiatrists and PMHNPs are fully capable of being the primary provider. Depression treatment typically relies on non-controlled medications (SSRIs, SNRIs, etc.), which all PMHNPs can prescribe regardless of state restrictions. The scope differences mainly come into play when treating co-occurring conditions (ADHD requiring stimulants, severe anxiety requiring benzodiazepines) or working across state lines.

The Economics: Why DIY Marketing Is More Expensive Than You Think

Here’s where we need to be honest about the business side of telehealth. You’ll see a lot of content online claiming you can acquire patients cheaply through DIY marketing — ‘just $30-50 per patient with SEO’ or similar nonsense. That’s not the reality most providers face.

Let’s break down what patient acquisition actually costs when you go it alone:

SEO (Search Engine Optimization): Getting your practice to rank on Google for ‘depression psychiatrist near me’ takes 6-12 months of consistent investment before you see meaningful patient flow. You’re either paying an agency $1,500-3,000/month or spending dozens of hours yourself on content, technical optimization, and link building. Even in the best case, you won’t see ROI for half a year.

Google Ads: Mental health keywords are expensive — $15-40+ per click. Most clicks don’t convert to booked patients. You’re testing ad copy, landing pages, audience targeting, burning through budget. A realistic cost per booked patient through PPC is $200-400+, and that’s after months of optimization. For new providers without experience managing campaigns, multiply that by 2-3x.

Directory Listings: Psychology Today charges $30/month base fee (more for premium placement), and you’re competing with hundreds of other providers in the same search results. Zocdoc charges per patient booking ($35-100+ depending on specialty and market), plus monthly subscription fees. When you add it all up — listing fees, time responding to inquiries, no-show rates from cold leads — you’re still looking at $150-300+ per acquired patient.

The Hidden Costs: Staff time to answer phone calls and qualify leads. No-shows from patients who weren’t properly screened. Failed campaigns that don’t convert. Consultant fees if you hire help. The opportunity cost of your time spent on marketing instead of seeing patients.

When you factor in all of these costs, acquiring a qualified psychiatric patient through DIY channels typically runs $200-500+ per patient. That’s the all-in cost when you account for testing, failed campaigns, and time to results.

Why Platforms Like Klarity Make Economic Sense

Compare that to Klarity Health’s model: you pay a standard listing fee per new patient lead. That’s it. No upfront marketing spend. No monthly subscription fees whether you see patients or not. No wasted ad dollars on clicks that don’t convert.

The patients who reach you are pre-qualified — they’re already matched to your specialty and availability. You’re not spending 20 minutes on the phone with someone who can’t afford treatment or isn’t actually ready to commit. The platform handles patient acquisition, intake screening, and scheduling. You show up and practice psychiatry.

You also get built-in telehealth infrastructure — no separate platform costs, no tech headaches. Klarity supports both insurance and cash-pay patients, so you’re not limiting your potential patient base.

Most importantly: you control your schedule and only pay when you see patients. If you take a week off, you’re not burning $2,000 in ad spend with nothing to show for it. The ROI is guaranteed — you know exactly what each patient costs, and you can do the math on whether it makes sense for your practice.

Could you eventually build a cost-effective DIY marketing machine? Sure — if you have the budget to sustain 6-12 months of investment, the expertise to manage campaigns (or the budget to hire someone who does), and the patience to test and optimize. For most providers, especially those starting out or looking to scale quickly, that’s a gamble. A platform that handles patient acquisition removes the risk entirely.

Practical Compliance: What You Need to Do

Whether you’re practicing through Klarity or another telehealth platform, here’s your compliance checklist:

Federal Requirements:

• Maintain a valid DEA registration in each state you practice
• Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances
• Use DEA-compliant e-prescribing software for controlled medications
• Document that you’re prescribing under the COVID-era telehealth extension (until the new permanent rules are finalized)
• Stay alert for DEA announcements about the new special registration requirements

State Requirements:

• Hold a valid medical or nursing license in the patient’s state (or telehealth registration where allowed, like Florida)
• For PMHNPs in restricted states: maintain an active collaborative agreement with a physician
• Obtain informed consent for telehealth services (some states require written documentation)
• Use HIPAA-compliant video platforms
• Follow your state’s standard of care for psychiatric evaluation — if you’d do a certain assessment in person, do it via telehealth
• Know your state’s specific controlled substance rules (like Florida’s psychiatric exception or Texas’s chronic pain prohibition)

Clinical Documentation:

• Document the telehealth modality (video, phone if permitted)
• Include mental status exam findings
• Note any safety screening (suicidality, homicidality)
• Document the clinical justification for controlled substance prescriptions
• Have an emergency plan if a patient is in crisis during a session
• For Schedule II prescriptions in states with special rules, explicitly note the indication (e.g., ‘Adderall 20mg daily for ADHD comorbid with major depression — treatment of psychiatric disorder’)

What’s Coming: Preparing for 2027 and Beyond

The DEA’s temporary extension expires December 31, 2026. By then, we should have final rules in place. Here’s what to expect and how to prepare:

For Psychiatrists: The proposed special registration for Schedule II telemedicine prescribing is written with you in mind. When the final rule is published, you’ll likely need to:

• Apply for the Advanced Telemedicine Prescribing registration
• Possibly meet certain requirements (board certification, continuing education in telehealth standards, etc.)
• Renew the registration periodically (similar to your DEA registration)

Start planning now. Make sure you’re board-certified (or board-eligible if within your certification window). Keep your CME current, especially in areas like opioid prescribing safety and telehealth best practices. When the registration opens, apply early to avoid any gaps in your ability to prescribe.

For PMHNPs: The current proposal doesn’t include you in the Schedule II category. This could change — the DEA is soliciting comments, and organizations like the American Association of Nurse Practitioners are advocating for inclusion. Submit comments during the public comment period if you want your voice heard.

Even if the final rule doesn’t include PMHNPs, you may still be able to prescribe Schedule II controlled substances via telehealth in states where you have full practice authority, as long as you meet whatever federal requirements apply to all prescribers. The rules are still being worked out.

For Schedule III-V substances (most benzodiazepines, ketamine, sleep aids), the proposed basic telemedicine registration should be available to you. That covers most of what you need for depression and anxiety management.

For Everyone: Expect the regulatory landscape to keep evolving. Bookmark the DEA’s website. Join your professional association’s advocacy efforts (APA for psychiatrists, AANP or ANCC for PMHNPs). Stay connected with platforms like Klarity that will keep you updated on compliance requirements.

The trend is toward more telehealth flexibility, not less. The DEA’s proposals include safeguards against abuse (platform registration, PDMP integration, reporting requirements), but they’re designed to preserve access to care. As long as you’re practicing good medicine, documenting appropriately, and following the rules, you should be able to continue providing telehealth psychiatric care.

FAQ: Your Most Common Questions Answered

Can I prescribe antidepressants via telehealth right now?
Yes. SSRIs, SNRIs, bupropion, mirtazapine, and other non-controlled antidepressants are not subject to DEA telehealth restrictions. As long as you conduct an appropriate evaluation (video visit in most states) and follow your state’s standard of care, you can prescribe these medications to new telehealth patients.

Can I prescribe stimulants like Adderall via telehealth for a patient with depression and ADHD?
Yes, through December 31, 2026, under the current DEA extension. After that, you’ll likely need the DEA’s special telemedicine registration. If you’re a psychiatrist, that registration should be available to you. If you’re a PMHNP, watch for the final rules — your eligibility may depend on your state’s scope of practice laws and whether the DEA expands the provider categories.

Do I need to see a patient in person before prescribing benzodiazepines via telehealth?
Not under current federal law (through 2026). Benzodiazepines are Schedule IV controlled substances, so they’re covered by the COVID-era telehealth flexibilities. You can initiate them via a video visit if clinically appropriate. Some states may have additional requirements, so check your state’s rules. After 2026, you may need a basic telemedicine special registration.

What’s the difference between practicing in a state with NP independence versus one that requires supervision?
In full practice states (CA with experience, NY after 3,600 hours, IL with FPA), PMHNPs can diagnose, treat, and prescribe independently without a collaborative agreement. You can join a platform like Klarity and see patients on your own. In restricted states (TX, FL, PA), you need a supervising or collaborating physician. That physician doesn’t have to be present during your telehealth sessions, but the relationship must be documented and they must be available for consultation. Some platforms can help connect you with collaborating physicians; others may require you to arrange that yourself.

I’m licensed in New York. Can I see patients in California via telehealth?
No. You must be licensed (or hold a valid telehealth registration) in the state where the patient is physically located during the visit. If the patient is in California, you need a California license, regardless of where you are. There are interstate compacts (IMLC for physicians in some states) that can make multi-state licensing easier, but neither California nor New York participates. You’d need to apply for full licensure in both states.

How much does it really cost to acquire a patient through Google Ads or SEO?
Honest answer: $200-500+ per patient when you account for all costs. Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert. SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You’re either paying an agency or investing significant time. Directory listings charge monthly fees and per-booking fees. When you add in staff time, no-shows, and failed campaigns, the true cost per acquired patient is much higher than the ‘$30-50’ figures some marketing content claims. Platforms that handle patient acquisition for a transparent per-patient fee often provide better ROI with less risk.

What happens if the DEA extension expires and new rules aren’t finalized?
That would be a worst-case scenario — the old Ryan Haight in-person requirement would snap back into effect, and you couldn’t prescribe controlled substances to new telehealth patients without seeing them in person first. However, the DEA and HHS have shown commitment to avoiding this ‘telemedicine cliff’ by issuing four extensions so far. They’ve also announced proposed rules, which suggests they’re working toward a permanent solution before the current extension ends. If you’re concerned, advocate through your professional association and stay tuned for updates.

I want to start seeing patients via telehealth — what’s the fastest way to get started?
If you’re already licensed in the state(s) where you want to practice, joining a telehealth platform is the quickest route. Platforms like Klarity Health handle patient acquisition, credentialing, scheduling, and provide the telehealth infrastructure. You focus on clinical care. If you’re a PMHNP in a restricted state, make sure you have (or can obtain) a collaborative agreement with a physician. If you’re planning multi-state practice, check which states you’re licensed in and whether you qualify for any compacts (IMLC for physicians, state-specific telehealth registrations like Florida’s). Get your DEA registration current, verify your malpractice insurance covers telehealth, and you’re ready to go.

Join Klarity Health: See More Patients, Skip the Marketing Headaches

If you’re a psychiatrist or PMHNP looking to expand your depression treatment practice via telehealth, Klarity Health offers a straightforward path. You get access to a steady stream of pre-qualified patients who are ready for treatment. You set your schedule and availability. You practice the way you want to practice — evidence-based psychiatry without administrative burden.

No upfront marketing costs. No gambling on ad campaigns. No months of waiting for SEO to kick in. Just a transparent, per-patient model that lets you grow your practice on your terms.

Explore Klarity Health’s provider network and see if it’s the right fit for your telehealth psychiatry practice. Whether you’re looking to supplement your in-person practice or build a full-time telehealth panel, Klarity handles the patient acquisition so you can focus on what you do best: helping people with depression get better.

Citations and Sources

1. U.S. Department of Health and Human Services. (January 2, 2026). HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. (January 16, 2025). DEA Announces Three New Telemedicine Rules to Continue Open Access to Care and Maintain Strong Safeguards. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Legislature. (2023). Florida Statutes §456.47 – Use of Telehealth to Provide Services. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Texas Medical Board. (January 15, 2025). Texas Administrative Code Title 22, Part 9, §174.5 – Telemedicine Issuance of Prescriptions. https://txrules.elaws.us/rule/title22chapter174sec.174.5

5. California Board of Registered Nursing. (2023). AB 890 Implementation – Nurse Practitioner Practice Without Standardized Procedures. https://www.rn.ca.gov/practice/ab890.shtml

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service